Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00227006 · ClinicalTrials.gov registry record · NA
Promoting Long-term Behavior Change to Reduce CVD Risk
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 163
- Enrollment target
NCT00227006: Completed NA study, sponsored by Stanford University.
NCT00227006 is a NA study that has completed, run by Stanford University. The registered enrollment target is 163 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00227006, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 163 participants
- Enrollment target
Study Summary
Once intervention class or staff contact is removed, obese adults participating in behavioral weight-loss programs often give up healthy eating habits and regain weight. We examined whether taste-based goal setting, which minimizes perceived deprivation by promoting taste and moderation, would sustain long-term reductions in saturated fat and body mass index (BMI).
Interventions
- BEHAVIORAL Behavioral lifestyle/weight-loss intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 1999-01 |
| Est. Completion | 2004-04 |
| Phase | NA |
What the finished NCT00227006 record still lists
NCT00227006 is an interventional study that assigns participants to a tested intervention. The registered 163 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which Behavioral lifestyle/weight-loss intervention is the first listed.
NCT00227006 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00227006 about?
NCT00227006 is a clinical study titled "Promoting Long-term Behavior Change to Reduce CVD Risk". Once intervention class or staff contact is removed, obese adults participating in behavioral weight-loss programs often give up healthy eating habits and regain weight. We examined whether taste-based goal setting, which minimizes perceived deprivation by promoting taste and moderation, would susta...
What is the current status of trial NCT00227006?
This trial is currently completed. It is a NA study. The enrollment target is 163 participants. The study started on 1999-01. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00227006?
The interventions under investigation include: Behavioral lifestyle/weight-loss intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00227006?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00227006's enrollment target sits among peer trials
163 627th of 2000 higher than 1,374 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03180268 · 163 participants · Phase 3
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- NCT04862221 · 163 participants · Phase 2
TReatment for ImmUne Mediated PathopHysiology
- NCT05702229 · 163 participants · Phase 2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT06137118 · 163 participants · Phase 1
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia